As of 2025-07-15, the Relative Valuation of Eli Lilly and Co (LLY) is 270.70 USD. This relative valuation is based on P/E multiples. With the latest stock price at 799.34 USD, the upside of Eli Lilly and Co based on Relative Valuation is -66.1%.
The range of the Relative Valuation is 212.11 - 324.14 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 27.7x | 22.9x |
| Forward P/E multiples | 19.3x - 21.8x | 20.6x |
| Fair Price | 212.11 - 324.14 | 270.70 |
| Upside | -73.5% - -59.4% | -66.1% |
| Date | P/E |
| 2025-07-14 | 68.21 |
| 2025-07-11 | 67.67 |
| 2025-07-10 | 67.47 |
| 2025-07-09 | 67.15 |
| 2025-07-08 | 66.36 |
| 2025-07-07 | 65.95 |
| 2025-07-03 | 66.62 |
| 2025-07-02 | 66.50 |
| 2025-07-01 | 66.21 |
| 2025-06-30 | 66.52 |
| 2025-06-27 | 66.17 |
| 2025-06-26 | 67.85 |
| 2025-06-25 | 67.61 |
| 2025-06-24 | 66.40 |
| 2025-06-23 | 65.76 |
| 2025-06-20 | 65.09 |
| 2025-06-18 | 66.99 |
| 2025-06-17 | 67.52 |
| 2025-06-16 | 68.91 |
| 2025-06-13 | 69.92 |
| 2025-06-12 | 69.29 |
| 2025-06-11 | 69.00 |
| 2025-06-10 | 68.88 |
| 2025-06-09 | 66.02 |
| 2025-06-06 | 65.70 |
| 2025-06-05 | 65.34 |
| 2025-06-04 | 65.35 |
| 2025-06-03 | 64.07 |
| 2025-06-02 | 63.75 |
| 2025-05-30 | 62.95 |
| 2025-05-29 | 61.66 |
| 2025-05-28 | 61.39 |
| 2025-05-27 | 61.89 |
| 2025-05-23 | 60.90 |
| 2025-05-22 | 61.03 |
| 2025-05-21 | 61.86 |
| 2025-05-20 | 63.74 |
| 2025-05-19 | 64.44 |
| 2025-05-16 | 64.63 |
| 2025-05-15 | 62.57 |
| 2025-05-14 | 61.06 |
| 2025-05-13 | 63.66 |
| 2025-05-12 | 64.47 |
| 2025-05-09 | 62.68 |
| 2025-05-08 | 64.12 |
| 2025-05-07 | 66.28 |
| 2025-05-06 | 66.14 |
| 2025-05-05 | 70.10 |
| 2025-05-02 | 70.28 |
| 2025-05-01 | 67.76 |